Navigation Links
Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
Date:9/5/2007

Lung Cancer

SCLC is the most aggressive and deadly form of lung cancer and accounts for approximately 20 percent of all lung cancer cases. The current two-year survival rate for patients with extensive SCLC is less than 10 percent with current management options. The estimated incidence of lung cancer in the United States in 2006 was 174,500, according to the National Cancer Institute. The estimated incidence in Europe in 2006 was 386,300, according to the International Agency for Research on Cancer.

SCLC is currently treated with platinum therapies, but many patients do not respond, and if they do respond, they typically relapse within a short time after treatment. There is currently no FDA-approved therapy and no consistent and effective therapy for SCLC patients who have platinum-resistant or -refractory disease after treatment failure with first-line combination therapy with either cisplatin or carboplatin. No new drugs have been approved by the FDA for the treatment of platinum-resistant or -refractory SCLC in nearly a decade.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company's lead product candidate, is a new generation platinum therapy with an improved safety profile. Picoplatin is designed to overcome and prevent platinum resistance associated with chemotherapy in solid tumors. Intravenous picoplatin is currently being studied in clinical trials for the treatment of small cell lung, colorectal and hormone-refractory prostate cancer, and oral picoplatin is in a clinical trial in solid tumors. As part of the Company's strategic goal of building a diverse oncology pipeline, the Company is collaborating with The Scripps Research Institute on the discovery of novel, small-molecule, multi-targeted protein kinase inhibitors. For additional infor
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
2. Poniard Pharmaceuticals Announces Clinical Data from Picoplatin Phase 2 Small Cell Lung Cancer Trial To Be Presented at American Society of Clinical Oncology Annual Meeting
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... Cardiologists at Henry Ford Hospital have implanted a device that ... heartbeat. With only handful of hospitals in the ... to add another option to its arsenal of tools for ... to pump. "This is a first in ... at a non-clinical trial site," says cardiologist Claudio Schuger ...
(Date:4/21/2015)... 21, 2015  St. Vincent Healthcare is raising ... Already following strict disinfection routines, St. Vincent Healthcare is ... eliminate harmful germs, like Ebola, methicillin-resistant Staphylococcus ... can infect patients during their hospital stay. ... Logo - http://photos.prnewswire.com/prnh/20150420/199749LOGO ...
(Date:4/21/2015)... smokers, was selected to present as a finalist at the American Heart Association,s Health Sciences Innovation ... Photo - http://photos.prnewswire.com/prnh/20150421/199989 ... ... ... of all cardiovascular disease is caused by smoking. The IntelliQuit™ device and mobile app ecosystem is ...
Breaking Medicine Technology:Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 2Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 3St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 2St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 3IntelliQuit World's First Smartphone Breathalyzer for Smokers to Present to American Heart Association Innovation Investment Forum 2IntelliQuit World's First Smartphone Breathalyzer for Smokers to Present to American Heart Association Innovation Investment Forum 3
... Volcano Corporation (NASDAQ: VOLC ), a leading ... guidance tools designed to enhance the treatment of coronary ... be participating in the William Blair & Company 31st ... The presentation by Scott Huennekens, president and chief ...
... 9, 2011 BD (Becton, Dickinson and Company) (NYSE: ... Heart to Heart International, a humanitarian medical aid nonprofit organization, ...  A team of 13 BD associates from around the world ... work with Heart to Heart partners at medical clinics to ...
Cached Medicine Technology:BD and Heart to Heart International Launch Volunteer Service Trip to Help "Build Back Better" in Haiti 2BD and Heart to Heart International Launch Volunteer Service Trip to Help "Build Back Better" in Haiti 3BD and Heart to Heart International Launch Volunteer Service Trip to Help "Build Back Better" in Haiti 4
(Date:4/21/2015)... FL (PRWEB) April 21, 2015 ... will honor Dina Tyler, Felton Institute’s Coordinator of ... and Recovery in Early Psychosis) Program in Alameda ... Excellence: Peer Specialist of the Year Award at ... the Oscars of behavioral health. , The Inspiring ...
(Date:4/21/2015)... Among parents of children with autism spectrum ... fair or poor, according to a study in the ... visit to the dentist can present many challenges for ... strange smells, loud noises, and sharp tools; the unfamiliarity ... the whole process—not knowing what will happen and when ...
(Date:4/21/2015)... Dallas, Texas (PRWEB) April 21, 2015 ... Review, H1 2015” provides comparative analysis on ... strengthens R&D pipelines by identifying new targets ... products. Complete report with TOC is available ... report also reviews key players involved in ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Wireless ... services, has been recognized by the Boston Business Journal ... The ranking was announced at a recent event celebrating ... list of the fastest-growing private companies in Massachusetts. , ... in the state that recorded the fastest revenue growth ...
(Date:4/21/2015)... WA (PRWEB) April 21, 2015 ... medical equipment and supplies, now represents Schiller ... Pressure Monitors, ECGs, Stress Tests, and Vital Signs ... based in Switzerland, is a global leader in ... Schiller's products are developed in close cooperation with ...
Breaking Medicine News(10 mins):Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 2Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 3Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 4Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 2Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 3Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 4Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 5Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 6Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Wireless Analytics Ranked as 25th Fastest Growing Private Company in Massachusetts 2Health News:QuickMedical Launches New Product Line: Schiller America 2Health News:QuickMedical Launches New Product Line: Schiller America 3
... Battlefield experience linked to hypertension years later, study finds ... in Iraq and Afghanistan who go into combat are ... long term than those who serve in supporting roles, ... combat exposures appeared to be a unique risk factor ...
... in the Seveso area of Italy, which was exposed to ... increased risk of developing cancer. Researchers writing in BioMed Central,s ... risk of breast cancer in women from the most exposed ... in all but the least exposed zone. Angela ...
... , LOS ALTOS, Calif., Sept. 14 InteKrin ... PhD has been named Chief Operating ... InteKrin,s Chief Scientific Officer after joining the Company earlier that ... had increasingly broad operational and strategic responsibility in key areas ...
... , LISLE, Ill., Sept. 14 Following a comprehensive New ... water, the Water Quality Association today urges consumers to consider installing final ... the newspaper reported results of its research in the second part of ... Ten percent of Americans "have been exposed to ...
... , , OKLAHOMA CITY ... speech to Congress and the nation Wednesday evening acknowledged that ... malpractice and the defensive medicine that preserves patient safety. ... and Medical Justice, a member based organization designed to protect ...
... ... cells hypothesis,• Laboratory study focused on breast cancer cells , ... Philadelphia, PA (Vocus) September 14, 2009 -- ... in mice longer than chemotherapy alone by targeting cancer stem cells, Harvard Medical School ...
Cached Medicine News:Health News:Combat Exposure Tied to Chronic High Blood Pressure 2Health News:Cancer risk raised after northern Italian industrial accident 2Health News:InteKrin Therapeutics Appoints Linda Slanec Higgins, PhD Chief Operating Officer 2Health News:Home Filtering Systems Provide Best Drinking Water Protection 2Health News:MedEncentive and Medical Justice Announce Partnership 2Health News:MedEncentive and Medical Justice Announce Partnership 3Health News:MedEncentive and Medical Justice Announce Partnership 4Health News:Diabetes Drug Kills Cancer Stem Cells in Combination Treatment in Mice 2Health News:Diabetes Drug Kills Cancer Stem Cells in Combination Treatment in Mice 3Health News:Diabetes Drug Kills Cancer Stem Cells in Combination Treatment in Mice 4Health News:Diabetes Drug Kills Cancer Stem Cells in Combination Treatment in Mice 5
Lyphochek Hemostasis Control is a multi-analyte control to help monitor coagulation factor assays and selected thrombosis risk assays. Assayed values are available for most major instrumentation....
... Liquichek Qualitative Urine Toxicology Control is a ... rapid urine drug screen panels, including Point ... test kits like Bio-Rad TOX/See, Biosite Triage ... qualitative results (+/) for popular kits and ...
Liquichek Reticulocyte Control is a human whole blood based control designed to monitor manual and automated methods for counting reticulocytes. Assayed values are provided at three clinically signif...
Liquichek Hematology Control (C) is an assayed hematology control for evaluating the performance of Coulter hematology instruments with complete CBC and VCS 5-part differential technology....
Medicine Products: